FIELD: medicine. SUBSTANCE: method involves administering calcium-containing preparations and myacalcic (salmon calcitonin) around implants. The latter is administered at a dose of 50-400 ED/day as nasal spray daily 5-7 days later after operation during 30 days. One more 15-days long treatment course is applied after 30 days long pause. It is repeated 6 and 12 months later and then every year. EFFECT: enhanced effectiveness of treatment. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIO-COMPOSITION MATERIAL APPLIED FOR OSTEOPLASTY | 2006 |
|
RU2325170C1 |
| THERMOGRAPHIC METHOD FOR DIAGNOSING HIP AND KNEE JOINT PROSTHESIS INSTABILITY | 2002 |
|
RU2197892C1 |
| METHOD OF BONE TISSUE GAIN | 2009 |
|
RU2392981C1 |
| METHOD OF PREDICTION OF HIP REPLACEMENT RESULTS | 2008 |
|
RU2373539C1 |
| METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2004 |
|
RU2269355C1 |
| METHOD FOR CREATING SUPPORT HIP JOINT NEARTHROSIS | 2003 |
|
RU2266068C2 |
| METHOD FOR INCREASING BONE MASS OF THE COTYLOID CAVITY DURING HIP REPLACEMENT IN PATIENTS WITH OSTEOPOROSIS | 2015 |
|
RU2598641C1 |
| METHOD OF ACETABULUM ARTHROPLASTY IN HIP JOINT ENDOPROSTHETICS | 2009 |
|
RU2396918C1 |
| SURGICAL METHOD FOR TREATING LOWER EXTREMITY DEFORMITIES IN CHILDREN HAVING DIASTROPHIC DYSPLASIA | 1999 |
|
RU2163101C1 |
| METHOD FOR PREDICTING RESULTS OF HIP JOINT TREATMENT USING ENDOPROSTHESIS | 2000 |
|
RU2173465C1 |
